CSIMarket


Protagonist Therapeutics inc   (PTGX)
Other Ticker:  
 

Protagonist Therapeutics inc

PTGX's Fundamental analysis








Looking into Protagonist Therapeutics Inc growth rates, revenue grew in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 23

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.31 %

Protagonist Therapeutics Inc realized net income compared to net loss a year ago in I. Quarter 2024

More on PTGX's Growth


Protagonist Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Protagonist Therapeutics Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 43.09 in trailing twelve-month period.
Company
12.74
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.


More on PTGX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 8.81

Protagonist Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Protagonist Therapeutics Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 43.09 in trailing twelve-month period.
Company
12.74
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.

Protagonist Therapeutics Inc Price to Book Ratio is at 3.45 lower than Indusry Avg. of 74.58. and higher than S&P 500 Avg. of 0.01

More on PTGX's Valuation

  Market Capitalization (Millions $) 1,934
  Shares Outstanding (Millions) 64
  Employees -
  Revenues (TTM) (Millions $) 315
  Net Income (TTM) (Millions $) 162
  Cash Flow (TTM) (Millions $) 45
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 8.81

  Market Capitalization (Millions $) 1,934
  Shares Outstanding (Millions) 64
  Employees -
  Revenues (TTM) (Millions $) 315
  Net Income (TTM) (Millions $) 162
  Cash Flow (TTM) (Millions $) 45
  Capital Exp. (TTM) (Millions $) -1


    PTGX's Profitability Comparisons
Protagonist Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2024 to 80.92 % from 38.42 % in IV. Quarter.

Protagonist Therapeutics Inc net profit margin of 81.32 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 8 in Healthcare sector and number 51 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 15.72
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.12
  Asset Turnover Ratio (TTM) 0.77
  Inventory Turnover Ratio (TTM) -



Protagonist Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2024 to 80.92 % from 38.42 % in IV. Quarter.

Protagonist Therapeutics Inc net profit margin of 81.32 % is currently ranking no. 6 in Major Pharmaceutical Preparations industry, ranking no. 8 in Healthcare sector and number 51 in S&P 500.

More on PTGX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com